Background Hydroxychloroquine is being administered among patients with COVID-19
infection in many healthcare systems across the world considering its in vitro effect against …

Background During the initial phases of the coronavirus disease 2019 (COVID-19)
epidemic, there was an unfounded fervor surrounding the use of hydroxychloroquine (HCQ); …

ABSTRACT COVID-19 has quickly become a public health problem worldwide, and
treatment for this new disease is needed. Hydroxychloroquine is an antimalarial that in vitro …

Background Hydroxychloroquine and chloroquine have been proposed as treatments for
coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from …

Aims Studies have indicated that chloroquine (CQ) shows antagonism against COVID-19 in
vitro. However, evidence regarding its effects in patients is limited. This study aims to …

Objective We performed a systematic review of the literature and meta-analysis on the
efficacy and safety of hydroxychloroquine to treat COVID-19 patients. Methods We searched …

Abstract Background and Objective The world is currently experiencing the Coronavirus
Disease-19 (COVID-19) pandemic. There is no approved drug for the definitive treatment of …

Being a pandemic and having a high global case fatality rate directed us to assess the
evidence strength of hydroxychloroquine efficacy in treating coronavirus disease‐2019 …

BACKGROUND: Hydroxychloroquine and chloroquine have been proposed as treatments
for coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from …

Background. The pandemic of coronavirus disease 2019 (COVID‐19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) resulted in an unprecedented …